RedShift BioAnalytics: Funding, Investors & Team (Oct 2026)
RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. It has developed a Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications. They started a new and developed MMS from the ground up specifically with the protein scientist in mind. The company was founded in 2005 and is headquartered in Burlington, Massachusetts.
RedShift BioAnalytics has raised $20.0M across 1 funding round on record, the most recent a Series E of $20.0M announced in Oct 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
RedShift BioAnalytics Company Profile and Key Stats
Latest funding round on record: Oct 2021.
RedShift BioAnalytics Funding Rounds
RedShift BioAnalytics Founders and Leadership Team
No contact details are on record for this team yet.
RedShift BioAnalytics Funding Compared to Other Biotechnology Startups
RedShift BioAnalytics' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like RedShift BioAnalytics in Biotechnology and Burlington
Companies Similar to RedShift BioAnalytics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
RedShift BioAnalytics Funding FAQs
What does RedShift BioAnalytics do?
RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. It has developed a Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications. They started a new and developed MMS from the ground up specifically with the protein scientist in mind. The company was founded in 2005 and is headquartered in Burlington, Massachusetts.
How much funding has RedShift BioAnalytics raised?
RedShift BioAnalytics has raised $20.0M across 1 round on record. The most recent is a Series E of $20.0M announced in Oct 2021.
When did RedShift BioAnalytics last raise funding?
RedShift BioAnalytics' most recent funding round on record is a Series E of $20.0M, announced in Oct 2021.
Who is the CEO of RedShift BioAnalytics?
Julien Bradley is listed as CEO at RedShift BioAnalytics.
Where is RedShift BioAnalytics headquartered?
RedShift BioAnalytics is based in Burlington, Massachusetts, United States.
How many employees does RedShift BioAnalytics have?
RedShift BioAnalytics is in the 11-50 employee band.
How does RedShift BioAnalytics' funding compare to other Biotechnology startups?
RedShift BioAnalytics' latest round of $20.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's RedShift BioAnalytics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RedShift BioAnalytics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.